Automated ECL Aptasensing Platform from an Intrarticular Radical Annihilation Route for Distinguishing Glioma Stages
Analytical Chemistry · 2024
DOI: 10.1021/acs.analchem.4c03890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Jing-Yi Bao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, College of Geography and En…. Hauptthemen laut MEDLINE: Glioma, Electrochemical Techniques, Luminescent Measurements, Biosensing Techniques. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Jinhua City.
Abstract (Originalsprache)
Nowadays, continuous efforts have been devoted to designing stable and high-efficiency electrochemiluminescence (ECL) emitters as alternatives for tris(2,2'-bipyridine)-ruthenium(II) (Ru(bpy)32+) in medical research. Herein, a novel ECL emitter was obtained by coordinating crystalline covalent triazinyl frameworks (cCTFs) with Ru2+ (termed Ru-cCTFs), which exhibited strong ECL emission by the ligand to metal charge transfer (LMCT) route. After its integration with 4-mercaptopyridine (SH-Py), the resultant SH-Py-Ru-cCTFs achieved 2.3-fold enhancement in the ECL efficiency by employing Ru(bpy)32+ as a standard, which involved a dynamic "intrarticular radical annihilation" ECL pathway. On such foundation, an automated ECL (A-ECL) aptasensor was constructed with an "on-off-on" model and magnetic separation upon linkage of the SH-Py-Ru-cCTFs with streptavidin (SA) magnetic beads (MBs). This automatic assay of miRNA-182 showed a wider linear range from 1.0 to 100.0 fM with a correlation coefficient (R2) of 0.994, a lower limit of detection (LOD) down to 0.28 fM, and faster operation within 41 min. Impressively, this bioassay facilely distinguished the stages of glioma disease from clinical blood samples with high accuracy. Hence, this research sheds light on how to develop advanced ECL luminophores and an automatic method, showing substantial insights into pathogenesis research of gliomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, College of Geography and Environmental Sciences, Zhejiang Normal University, Jinhua 321004, China.
- Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Donghu Road 169, Wuhan 430071, China.
ORCID-Profile: Ai-Jun Wang, Pei-Xin Yuan, Jiu-Ju Feng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Jinhua City
Zitieren
APA
Bao, J. Y., Liu, W., Chen, C., Zhu, H. T., Wang, A. J., Yuan, P. X., & Feng, J. J. (2024). Automated ECL Aptasensing Platform from an Intrarticular Radical Annihilation Route for Distinguishing Glioma Stages. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c03890
Vancouver
Bao JY, Liu W, Chen C, Zhu HT, Wang AJ, Yuan PX, et al. Automated ECL Aptasensing Platform from an Intrarticular Radical Annihilation Route for Distinguishing Glioma Stages. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c03890
BibTeX
@article{Bao2024,
author = {Bao, Jing-Yi and Liu, Wen and Chen, Can and Zhu, Hao-Tian and Wang, Ai-Jun and Yuan, Pei-Xin and Feng, Jiu-Ju},
title = {Automated ECL Aptasensing Platform from an Intrarticular Radical Annihilation Route for Distinguishing Glioma Stages},
journal = {Analytical Chemistry},
year = {2024},
doi = {10.1021/acs.analchem.4c03890}
}
EUVIMED